These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 30863636)

  • 1. Apolipoprotein C-II Mimetic Peptide Promotes the Plasma Clearance of Triglyceride-Rich Lipid Emulsion and the Incorporation of Fatty Acids into Peripheral Tissues of Mice.
    Komatsu T; Sakurai T; Wolska A; Amar MJ; Sakurai A; Vaisman BL; Sviridov D; Demosky S; Pryor M; Ikewaki K; Remaley AT
    J Nutr Metab; 2019; 2019():7078241. PubMed ID: 30863636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of plasma apolipoproteins on lipoprotein lipase-mediated lipolysis of small and large lipid emulsions.
    Yamamoto M; Morita SY; Kumon M; Kawabe M; Nishitsuji K; Saito H; Vertut-Doï A; Nakano M; Handa T
    Biochim Biophys Acta; 2003 Jun; 1632(1-3):31-9. PubMed ID: 12782148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surface composition regulates clearance from plasma and triolein lipolysis of lipid emulsions.
    Arimoto I; Matsumoto C; Tanaka M; Okuhira K; Saito H; Handa T
    Lipids; 1998 Aug; 33(8):773-9. PubMed ID: 9727607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A dual apolipoprotein C-II mimetic-apolipoprotein C-III antagonist peptide lowers plasma triglycerides.
    Wolska A; Lo L; Sviridov DO; Pourmousa M; Pryor M; Ghosh SS; Kakkar R; Davidson M; Wilson S; Pastor RW; Goldberg IJ; Basu D; Drake SK; Cougnoux A; Wu MJ; Neher SB; Freeman LA; Tang J; Amar M; Devalaraja M; Remaley AT
    Sci Transl Med; 2020 Jan; 12(528):. PubMed ID: 31996466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipoprotein ApoC-II activation of lipoprotein lipase. Modulation by apolipoprotein A-IV.
    Goldberg IJ; Scheraldi CA; Yacoub LK; Saxena U; Bisgaier CL
    J Biol Chem; 1990 Mar; 265(8):4266-72. PubMed ID: 2307668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. WAT apoC-I secretion: role in delayed chylomicron clearance in vivo and ex vivo in WAT in obese subjects.
    Cyr Y; Wassef H; Bissonnette S; Lamantia V; Davignon J; Faraj M
    J Lipid Res; 2016 Jun; 57(6):1074-85. PubMed ID: 27040450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Creation of Apolipoprotein C-II (ApoC-II) Mutant Mice and Correction of Their Hypertriglyceridemia with an ApoC-II Mimetic Peptide.
    Sakurai T; Sakurai A; Vaisman BL; Amar MJ; Liu C; Gordon SM; Drake SK; Pryor M; Sampson ML; Yang L; Freeman LA; Remaley AT
    J Pharmacol Exp Ther; 2016 Feb; 356(2):341-53. PubMed ID: 26574515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endogenous apoC-I increases hyperlipidemia in apoE-knockout mice by stimulating VLDL production and inhibiting LPL.
    Westerterp M; de Haan W; Berbée JF; Havekes LM; Rensen PC
    J Lipid Res; 2006 Jun; 47(6):1203-11. PubMed ID: 16537968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of sphingomyelin and cholesterol on lipoprotein lipase-mediated lipolysis in lipid emulsions.
    Arimoto I; Saito H; Kawashima Y; Miyajima K; Handa T
    J Lipid Res; 1998 Jan; 39(1):143-51. PubMed ID: 9469593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood clearance kinetics and organ delivery of medium-chain triglyceride and fish oil-containing lipid emulsions: Comparing different animal species.
    Hu C; Ding H; Zhuang Q; Llanos P; Pillay T; Hernandez C; Carpentier YA; Deckelbaum RJ; Chang CL
    Clin Nutr; 2021 Mar; 40(3):987-996. PubMed ID: 32753350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ApoC-III ASO promotes tissue LPL activity in the absence of apoE-mediated TRL clearance.
    Ramms B; Patel S; Nora C; Pessentheiner AR; Chang MW; Green CR; Golden GJ; Secrest P; Krauss RM; Metallo CM; Benner C; Alexander VJ; Witztum JL; Tsimikas S; Esko JD; Gordts PLSM
    J Lipid Res; 2019 Aug; 60(8):1379-1395. PubMed ID: 31092690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enrichment of Triglyceride-Rich Lipoproteins with Apolipoprotein C-I Is Positively Associated with Their Delayed Plasma Clearance Independently of Other Transferable Apolipoproteins in Postmenopausal Overweight and Obese Women.
    Wassef H; Bissonnette S; Dufour R; Davignon J; Faraj M
    J Nutr; 2017 May; 147(5):754-762. PubMed ID: 28356429
    [No Abstract]   [Full Text] [Related]  

  • 13. Omega-3 triglycerides modify blood clearance and tissue targeting pathways of lipid emulsions.
    Qi K; Seo T; Al-Haideri M; Worgall TS; Vogel T; Carpentier YA; Deckelbaum RJ
    Biochemistry; 2002 Mar; 41(9):3119-27. PubMed ID: 11863451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apolipoprotein C-III deficiency accelerates triglyceride hydrolysis by lipoprotein lipase in wild-type and apoE knockout mice.
    Jong MC; Rensen PC; Dahlmans VE; van der Boom H; van Berkel TJ; Havekes LM
    J Lipid Res; 2001 Oct; 42(10):1578-85. PubMed ID: 11590213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human apolipoprotein A-II determines plasma triglycerides by regulating lipoprotein lipase activity and high-density lipoprotein proteome.
    Julve J; Escolà-Gil JC; Rotllan N; Fiévet C; Vallez E; de la Torre C; Ribas V; Sloan JH; Blanco-Vaca F
    Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):232-8. PubMed ID: 19910634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood clearance and tissue uptake of intravenous lipid emulsions containing long-chain and medium-chain triglycerides and fish oil in a mouse model.
    Treskova E; Carpentier YA; Ramakrishnan R; Al-Haideri M; Seo T; Deckelbaum RJ
    JPEN J Parenter Enteral Nutr; 1999; 23(5):253-7; discussion 258-9. PubMed ID: 10485437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. White adipose tissue apolipoprotein C-I secretion in relation to delayed plasma clearance of dietary fat in humans.
    Wassef H; Salem H; Bissonnette S; Baass A; Dufour R; Davignon J; Faraj M
    Arterioscler Thromb Vasc Biol; 2012 Nov; 32(11):2785-93. PubMed ID: 22995522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoproteins C-I and C-III inhibit lipoprotein lipase activity by displacement of the enzyme from lipid droplets.
    Larsson M; Vorrsjö E; Talmud P; Lookene A; Olivecrona G
    J Biol Chem; 2013 Nov; 288(47):33997-34008. PubMed ID: 24121499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of particle size on blood clearance and tissue uptake of lipid emulsions with different triglyceride compositions.
    Qi K; Al-Haideri M; Seo T; Carpentier YA; Deckelbaum RJ
    JPEN J Parenter Enteral Nutr; 2003; 27(1):58-64. PubMed ID: 12549600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presence of apolipoprotein C-III attenuates apolipoprotein E-mediated cellular uptake of cholesterol-containing lipid particles by HepG2 cells.
    Morita SY; Sakurai A; Nakano M; Kitagawa S; Handa T
    Lipids; 2011 Apr; 46(4):323-32. PubMed ID: 21080234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.